Results 151 to 160 of about 9,502,784 (300)

Plant-Based Production of Human Major Histocompatibility Complex Class II Molecules. [PDF]

Plant Biotechnol J
Ramadan A, Miyadera H, Oka K, Ishikawa K, Kobayashi T, Kobayashi M, Shiroishi M, Noguchi E, Miura K.   +8 more
europepmc   +1 more source

Temperature homeostasis disruption and hypothalamic alterations in experimental drug‐resistant epilepsy

Epilepsia, EarlyView.
Abstract Objective Elevated body temperature may increase seizure risk, yet the relationship between thermoregulation and seizures, as well as the underlying mechanisms, remains poorly understood. We investigated whether thermoregulatory control is altered in experimental temporal lobe epilepsy (TLE), as such impairment could reduce the ability of ...
Rossella Di Sapia, Akash Bera, Omar Mamad, James D. Mills, Benjamin Villasana‐Salazar, Giada Lavigna, Edoardo Micotti, Manuela Conticello, Asmin Alam, Roberto Chiesa, Francesca Pagani, Roberta Frapolli, Angelo M. Lavecchia, Christodoulos Xinaris, Eleonora Aronica, Andre Altmann, Teresa Ravizza, Sanjay M. Sisodiya, David C. Henshall, Annamaria Vezzani   +19 more
wiley   +1 more source

Major histocompatibility complex class II deficiency in Morocco: a 26-year retrospective cohort study. [PDF]

Front Immunol
Kattra AB, Ailal F, Benhsaien I, Rada N, Admou B, Hazime R, Benajiba N, El Hafidi N, Hbibi M, Hida M, Rkain M, El Boussaadni Y, Oulmaati A, Bousfiha AA, El Bakkouri J.   +14 more
europepmc   +1 more source

Composition of allogeneic equine orthobiologics and their repeated intra‐articular administrations

Equine Veterinary Journal, EarlyView.
Abstract Background Orthobiologics such as platelet‐rich plasma (PRP) and alpha‐2‐macroglobulin (A2MG) are increasingly used for equine musculoskeletal injuries. However, their composition and safety with repeated allogeneic intra‐articular administration remain poorly investigated.
Yanne Van Reusel, Sarah Y. Broeckx, Anna Carolo, Marco Patruno, Jonas Steenbrugge, Jimmy Saunders, Enrico Gugliandolo, Jan H. Spaas   +7 more
wiley   +1 more source

Long-term major histocompatibility complex class I suppression in astronauts and clinical implications. [PDF]

Commun Biol
LeRoy E, Kim J, Ruland H, Schanzer N, Sakharkar A, Innes L, Feinstein Z, Gamboa DZ, Chen R, Arikatla MR, Kurt KC, Crucian BE, Schmidt MA, Mason CE.   +13 more
europepmc   +1 more source

Major Histocompatibility Complex Genomic Regions as Candidates for Reproductive Success in Cattle: From GWAS to Post-GWAS Analysis. [PDF]

Genes (Basel)
Faverzani LB, Zwirtes AK, Rodrigues DPA, Machado TF, Oliveira DA, Silveira LC, Seixas NP, Silva EN, Silva DBS, Vaz RZ, Melo TP.   +10 more
europepmc   +1 more source

Phosphorylation-Dependent Charge Transport in Biomolecular Junctions of Major Histocompatibility Complex Phosphopeptides. [PDF]

J Phys Chem B
Thompson W, Burrows J, Safavi-Sohi R, Rostami Osanloo M, Sadeghi H, Morgenstern A, Ashkarran AA.   +6 more
europepmc   +1 more source

Cysteine Peptidases in Antitumor Immunity: Unraveling Antigen‐Presenting Cell Regulation and Therapeutic Potential

iMetaMed, EarlyView.
This review systematically summarizes the central role of cysteine peptidases in modulating antigen‐presenting cell (APC) function and antitumor immune responses, highlighting their critical significance in overcoming tumor immune evasion. Current research has established that cysteine peptidase subtypes, including cathepsins B, S, L, and X, exert ...
Yimao Wu, Xiaoyan Chen, Zichang Chen, Yalun Liang, Gokhan Zengin, Qian Zhang, Wenlong Sun, Meng‐Yao Li   +7 more
wiley   +1 more source

Advances in Immunological Combination Therapy for Colorectal Cancer

iMetaMed, EarlyView.
Review the progress of combined immunotherapy for colorectal cancer. ABSTRACT Immune checkpoint inhibitors (ICIs) have been utilized extensively and shown to be therapeutically beneficial in the treatment of solid tumors in recent years. Nonetheless, considerable heterogeneity in Colorectal cancer (CRC) requires careful consideration.
Jiayue Wu, Rongbo Wen, Tianshuai Zhang, Fuao Cao, Xiaoming Zhu, Liqiang Hao, Wei Zhang, Guanyu Yu   +7 more
wiley   +1 more source

Major histocompatibility complex II serves as a prognostic biomarker in resectable pulmonary sarcomatoid carcinoma: development of a prediction model. [PDF]

Transl Lung Cancer Res
Wang H, Ye L, Liu X, Li Y, Chen Z, Zhang W, Liu Y, Chen X, Zhao W, Zhang Q, Huang R, Zeng J, Chen S, Li Y, Zhao L, Xu K, He Y.   +16 more
europepmc   +1 more source